Med Terms #4 Flashcards

(313 cards)

1
Q

Finish this sentence:

INDICATIONS: Severe pain, pain, and anxiety associated with CPAP use in ___ edema

For fentanyl

A

pulmonary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Finish this sentence:

PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been ___. Naloxone should be considered prior to securing airway with ET tube

For Naloxone

A

intubated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Finish this sentence:

DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending ___ pathways.

For fentanyl

A

pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

(Paresthesia) tingling or ___ of the skin, also known as “pins and needles” or a limb “falling asleep”

A

prickling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Finish this sentence:

Cholinergic Poisoning: 0.05 mg/kg IV push every 15 minutes until decreased secretions; 1 mg IM every 15 minutes if ___ IV

For Atropine

A

NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Finish this sentence:

DOSAGE: Adult Dose = 1 mcg/kg, max 100 ___, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg

For fentanyl

A

mcg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Finish this sentence:

ADVERSE REACTIONS: Flushed skin * Tachycardia * Dry mouth * Dilated pupils * ___ * Blurred vision * headache

For Atropine

A

Delirium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Finish this sentence:

DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 ___/___, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg

For fentanyl

A

mcg/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Finish this sentence:

ADVERSE REACTIONS: Pulmonary edema, severe agitation, ___, dysrhythmias, & tachycardia

For Naloxone

A

hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Finish this sentence:

Pediatric Bradycardia: 0.02 mg/kg rapid ___ push every 5 minutes, minimum dose 0.1 mg. Max dose: 1mg child; 2mg adolescent.

For Atropine

A

IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Finish this sentence:

Fentanyl - (Sublimaze, Duragsesic, Actiq, Fentora) / Opiate ___

A

agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Finish this sentence:

DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 ___. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg

For Naloxone

A

mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Finish this sentence:

ADVERSE REACTIONS: ___ edema, severe agitation, hypertension, dysrhythmias, & tachycardia

For Naloxone

A

Pulmonary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Finish this sentence:

Pediatric Bradycardia: ___ mg/kg rapid IV push every 5 minutes, minimum dose 0.1 mg. Max dose: 1mg child; 2mg adolescent.

For Atropine

A

0.02

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

(Paresthesia) tingling or prickling of the skin, also known as “___ ___ ___” or a limb “falling asleep”

A

pins and needles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

(Sternutate) ___

A

sneeze

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

(Rhinorrhea) ___ nose

A

runny

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Finish this sentence:

Pediatric Bradycardia: 0.02 mg/kg rapid IV push every ___ minutes, minimum dose 0.1 mg. Max dose: 1mg child; 2mg adolescent.

For Atropine

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Finish this sentence:

DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 ___. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg

For fentanyl

A

mcg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

(___) when your eyes hurt whenever you step outside because it’s too bright; light-induced pain of the irises

A

Photalgia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Finish this sentence:

ADVERSE REACTIONS: Flushed skin * Tachycardia * Dry mouth * Dilated pupils * ___ * Blurred vision * headache

For Atropine

A

Delirium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Finish this sentence:

DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max ___ mcg, every 5 minutes, max cumulative dose 200 mcg

For fentanyl

A

50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

(Photalgia) when your ___ hurt whenever you step outside because it’s too bright; light-induced pain of the irises

A

eyes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Finish this sentence:

ADVERSE REACTIONS: Drowsiness * Nausea / vomiting * Respiratory ___, apnea * Bradycardia

For fentanyl

A

depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending pain ___. ## Footnote For fentanyl
pathways
26
(___) the descent of any internal organ (prolapse)
Procidentia
27
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 ___ - Max cumulative dose 12 mg ## Footnote For Naloxone
mins
28
# Finish this sentence: INDICATIONS: Narcotic ___. Unresponsiveness of unknown etiology ## Footnote For Naloxone
overdose
29
(Procidentia) the descent of any internal organ (___)
prolapse
30
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow complex (Mobitz ___ ___) AV block * Cholinergic poisoning (organophosphate or nerve agents) ## Footnote For Atropine
Type I
31
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/kg rapid IV push every 5 minutes, minimum dose 0.1 mg. Max dose: 1 ___ child; 2mg adolescent. ## Footnote For Atropine
mg
32
# Finish this sentence: INDICATIONS: Severe pain, pain, and anxiety associated with ___ use in pulmonary edema ## Footnote For fentanyl
CPAP
33
# Finish this sentence: DOSAGE: Adult Bradycardia: 1 mg rapid IV push every 3-5 minutes (max dose 3 ___) ## Footnote For Atropine
mg
34
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - ___ cumulative dose 12 mg ## Footnote For Naloxone
Max
35
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max ___ dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
cumulative
36
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters ___ perception and increases pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
pain
37
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: ___ the effects of all narcotics. Blocks opioid receptors which prevent narcotics from binding. ## Footnote For Naloxone
Reverses
38
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: ___ mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
4
39
(Photalgia) when your eyes ___ whenever you step outside because it’s too bright; light-induced pain of the irises
hurt
40
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 ___ slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
mg
41
(Proctalgia) ___ pain in the butt
literal
42
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, ___ ___, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
GI distress
43
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * ___ complex (Mobitz Type I) AV block * Cholinergic poisoning (organophosphate or nerve agents) ## Footnote For Atropine
Narrow
44
(___) sneeze
Sternutate
45
# Finish this sentence: DOSAGE: Adult Dose = 1 ___/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
mcg
46
(Pneumoultramicro___ilicovolcanoconiosis) lung disease from inhaling very fine ash and sand (or “silica dust”); also known as silicosis or the black lung
scopics
47
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe hepatic or renal impairment * Severe respiratory depression * Severe ___ asthma * Paralytic ileus ## Footnote For fentanyl
bronchial
48
# Finish this sentence: CONTRAINDICATIONS: ___ / Aflutter with rapid ventricular response (RVR) * Mobitz Type II AV Blocks * Wide Complex 3rd degree AV blocks * Myocardial ischemia ## Footnote For Atropine
Afib
49
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe hepatic or renal impairment * ___ respiratory depression * Severe bronchial asthma * Paralytic ileus ## Footnote For fentanyl
Severe
50
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: ___ heart rate in bradycardia, thus improving cardiac output and decreases chance of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
Accelerates
51
(Pyrexia) ___
fever
52
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO ___. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
doses
53
(Photalgia) when your eyes hurt whenever you step outside because it’s ___ bright; light-induced pain of the irises
too
54
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe hepatic or renal ___ * Severe respiratory depression * Severe bronchial asthma * Paralytic ileus ## Footnote For fentanyl
impairment
55
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat ___ mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
q2-3
56
# Finish this sentence: ADVERSE REACTIONS: Pulmonary edema, severe agitation, hypertension, ___, & tachycardia ## Footnote For Naloxone
dysrhythmias
57
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * ___ hepatic or renal impairment * Severe respiratory depression * Severe bronchial asthma * Paralytic ileus ## Footnote For fentanyl
Severe
58
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, ___, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
agitation
59
(Prosopagnosia) inability to recognize ___
faces
60
# Finish this sentence: ADVERSE REACTIONS: ___ * Nausea / vomiting * Respiratory depression, apnea * Bradycardia ## Footnote For fentanyl
Drowsiness
61
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/kg rapid IV push every 5 minutes, minimum dose 0.1 ___. Max dose: 1mg child; 2mg adolescent. ## Footnote For Atropine
mg
62
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / ___ ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
0.1
63
(Pneumoultramicroscopics___volcanoconiosis) lung disease from inhaling very fine ash and sand (or “silica dust”); also known as silicosis or the black lung
ilico
64
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal ___ (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
syndrome
65
(Rhinorrhea) runny ___
nose
66
(Prosopagnosia) inability to ___ faces
recognize
67
(Photalgia) when your eyes hurt whenever you step ___ because it’s too bright; light-induced pain of the irises
outside
68
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for ___ and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
THIRD
69
Pyrexia
fever
70
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac output and decreases chance of ventricular ectopy. ___ mucous membranes in organophosphate poisoning. ## Footnote For Atropine
Dries
71
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, ___ to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
Binds
72
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. ___ should be considered prior to securing airway with ET tube ## Footnote For Naloxone
Naloxone
73
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate ___ withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
opioid
74
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow complex (Mobitz Type I) AV block * Cholinergic ___ (organophosphate or nerve agents) ## Footnote For Atropine
poisoning
75
(___) literal pain in the butt
Proctalgia
76
# Finish this sentence: PRECAUTIONS: Renal ___ * CHF * Down’s Syndrome ## Footnote For Atropine
disease
77
# Finish this sentence: Fentanyl - (Sublimaze, ___, Actiq, Fentora) / Opiate agonist
Duragsesic
78
# Finish this sentence: CONTRAINDICATIONS: ___ sensitivity to the drug ## Footnote For Naloxone
Known
79
# Finish this sentence: PRECAUTIONS: Do not use with MAOIs (___ oxidase inhibitors) ## Footnote For fentanyl
monoamine
80
# Finish this sentence: ___ - (Sublimaze, Duragsesic, Actiq, Fentora) / Opiate agonist
Fentanyl
81
(Pneumoultramicroscopicsilicovalcano___) lung disease from inhaling very fine ash and sand (or “silica dust”); also known as silicosis or the black lung
coniosis
82
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). ___ should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
Naloxone
83
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and ___). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
yawning
84
(Prosopagnosia) ___ to recognize faces
inability
85
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 ___ ## Footnote For Naloxone
mg
86
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac output and decreases ___ of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
chance
87
# Finish this sentence: Cholinergic Poisoning: 0.05 mg/kg IV push every 15 minutes until decreased secretions; 1 mg IM every 15 minutes if NO ___ ## Footnote For Atropine
IV
88
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain ___ and increases pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
perception
89
# Finish this sentence: Cholinergic Poisoning: 0.05 mg/kg IV push every 15 minutes until ___ secretions; 1mg IM every 15 minutes if NO IV ## Footnote For Atropine
decreased
90
# Finish this sentence: Fentanyl - (Sublimaze, Duragsesic, Actiq, ___) / Opiate agonist
Fentora
91
# Finish this sentence: INDICATIONS: Severe ___, pain, and anxiety associated with CPAP use in pulmonary edema ## Footnote For fentanyl
pain
92
# Finish this sentence: Cholinergic Poisoning: 0.05 mg/kg IV push every ___ minutes until decreased secretions; 1mg IM every 15 minutes if NO IV ## Footnote For Atropine
15
93
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe ___ or renal impairment * Severe respiratory depression * Severe bronchial asthma * Paralytic ileus ## Footnote For fentanyl
hepatic
94
# Finish this sentence: Fentanyl - (Sublimaze, Duragsesic, Actiq, Fentora) / ___ agonist
Opiate
95
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = ___ mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
0.5
96
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac output and ___ chance of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
decreases
97
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates ___ rate in bradycardia, thus improving cardiac output and decreases chance of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
heart
98
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac output and decreases chance of ventricular ectopy. Dries mucous ___ in organophosphate poisoning. ## Footnote For Atropine
membranes
99
# Finish this sentence: Cholinergic Poisoning: 0.05 mg/kg IV push every 15 minutes until decreased secretions; 1 mg IM every 15 minutes if NO ___ ## Footnote For Atropine
IV
100
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 ___ / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
mg
101
# Finish this sentence: Fentanyl - (___, Duragsesic, Actiq, Fentora) / Opiate agonist
Sublimaze
102
# Finish this sentence: PRECAUTIONS: Renal disease * ___ * Down’s Syndrome ## Footnote For Atropine
CHF
103
# Finish this sentence: ADVERSE REACTIONS: ___ skin * Tachycardia * Dry mouth * Dilated pupils * Delirium * Blurred vision * headache ## Footnote For Atropine
Flushed
104
(___palatine Ganglioneuralgia) brain freeze; having a headache from ice cream
Spheno
105
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ___ IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
ml
106
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid ___ syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
withdrawal
107
(Proctalgia) literal ___ in the butt
pain
108
(___) tingling or prickling of the skin, also known as “pins and needles” or a limb “falling asleep”
Paresthesia
109
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST ___ doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
TWO
110
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe hepatic or renal impairment * Severe respiratory depression * Severe bronchial ___ * Paralytic ileus ## Footnote For fentanyl
asthma
111
(Procidentia) the descent of any internal ___ (prolapse)
organ
112
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory ___ endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
nerve
113
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every ___ minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
5
114
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow ___/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
IV
115
# Finish this sentence: ADVERSE REACTIONS: Pulmonary edema, ___ agitation, hypertension, dysrhythmias, & tachycardia ## Footnote For Naloxone
severe
116
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose ___ mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
12
117
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg ___ IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
slow
118
# Finish this sentence: ADVERSE REACTIONS: Flushed skin * ___ * Dry mouth * Dilated pupils * Delirium * Blurred vision * headache ## Footnote For Atropine
Tachycardia
119
# Finish this sentence: PRECAUTIONS: ___ does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
Naloxone
120
# Finish this sentence: DOSAGE:Adult: 4 mg / ___ ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
0.1
121
# Finish this sentence: PRECAUTIONS: Do not use with MAOIs (monoamine oxidase ___) ## Footnote For fentanyl
inhibitors
122
# Finish this sentence: PRECAUTIONS: Do not use with ___ (monoamine oxidase inhibitors) ## Footnote For fentanyl
MAOIs
123
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, ___, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
vomiting
124
# Finish this sentence: INDICATIONS: Narcotic overdose. Unresponsiveness of ___ etiology ## Footnote For Naloxone
unknown
125
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 ___ slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
mg
126
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max ___ dose 12 mg ## Footnote For Naloxone
cumulative
127
# Finish this sentence: CONTRAINDICATIONS: Increased ___ * Severe hepatic or renal impairment * Severe respiratory depression * Severe bronchial asthma * Paralytic ileus ## Footnote For fentanyl
ICP
128
# Finish this sentence: DOSAGE: Adult Bradycardia: 1 ___ rapid IV push every 3-5 minutes (max dose 3 mg) ## Footnote For Atropine
mg
129
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Reverses the effects of all narcotics. Blocks opioid receptors which prevent ___ from binding. ## Footnote For Naloxone
narcotics
130
(Spheno___ Ganglioneuralgia) brain freeze; having a headache from ice cream
palatine
131
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Reverses the effects of all narcotics. Blocks ___ receptors which prevent narcotics from binding. ## Footnote For Naloxone
opioid
132
# Finish this sentence: INDICATIONS: Narcotic overdose. Unresponsiveness of unknown ___ ## Footnote For Naloxone
etiology
133
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac output and decreases chance of ventricular ___. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
ectopy
134
# Finish this sentence: CONTRAINDICATIONS: ___ / Aflutter with rapid ventricular response (RVR) * Mobitz Type II AV Blocks * Wide Complex 3rd degree AV blocks * Myocardial ischemia ## Footnote For Atropine
Afib
135
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Reverses the effects of all narcotics. Blocks opioid receptors which ___ narcotics from binding. ## Footnote For Naloxone
prevent
136
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/kg ___ IV push every 5 minutes, minimum dose 0.1 mg. Max dose: 1mg child; 2mg adolescent. ## Footnote For Atropine
rapid
137
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose ___ mg ## Footnote For Naloxone
12
138
# Finish this sentence: ATROPINE -(Atropine)/Anti___, parasympatholytic
cholinergic
139
# Finish this sentence: ATROPINE -(Atropine)/Anticholinergic, ___sympatholytic
para
140
# Finish this sentence: PRECAUTIONS: ___ disease * CHF * Down’s Syndrome ## Footnote For Atropine
Renal
141
# Finish this sentence: ADVERSE REACTIONS: Drowsiness * Nausea / vomiting * ___ depression, apnea * Bradycardia ## Footnote For fentanyl
Respiratory
142
(Photalgia) when your eyes hurt whenever you step outside because it’s too bright; ___ pain of the irises
light-induced
143
# Finish this sentence: Cholinergic Poisoning: 0.05 mg/kg IV push every 15 minutes until decreased ___; 1mg IM every 15 minutes if NO IV ## Footnote For Atropine
secretions
144
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve ___ and inhibiting ascending pain pathways. ## Footnote For fentanyl
endings
145
(Paresthesia) tingling or prickling of the ___, also known as “pins and needles” or a limb “falling asleep”
skin
146
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/___ push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
IO
147
# Finish this sentence: INDICATIONS: Severe pain, ___, and anxiety associated with CPAP use in pulmonary edema ## Footnote For fentanyl
pain
148
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/kg rapid IV ___ every 5 minutes, minimum dose 0.1 mg. Max dose: 1mg child; 2mg adolescent. ## Footnote For Atropine
push
149
# Finish this sentence: NALOXONE-(Narcan)/ Narcotic ___
antagonist
150
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (___, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
anxiety
151
# Finish this sentence: PRECAUTIONS: Do not use with MAOIs (monoamine ___ inhibitors) ## Footnote For fentanyl
oxidase
152
# Finish this sentence: ADVERSE REACTIONS: Drowsiness * Nausea / vomiting * Respiratory depression, ___ * Bradycardia ## Footnote For fentanyl
apnea
153
(Photalgia) when your eyes hurt whenever you step outside because it’s too bright; light-induced ___ of the irises
pain
154
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 ___ ## Footnote For Naloxone
mg
155
# Finish this sentence: DOSAGE: Adult Bradycardia: 1 mg ___ IV push every 3-5 minutes (max dose 3 mg) ## Footnote For Atropine
rapid
156
(Pneumoultra___scopicsilicovolcanoconiosis) lung disease from inhaling very fine ash and sand (or “silica dust”); also known as silicosis or the black lung
micro
157
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe hepatic or ___ impairment * Severe respiratory depression * Severe bronchial asthma * Paralytic ileus ## Footnote For fentanyl
renal
158
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 ___: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
kg
159
# Finish this sentence: INDICATIONS: Severe pain, pain, and anxiety associated with CPAP use in pulmonary ___ ## Footnote For fentanyl
edema
160
# Finish this sentence: Cholinergic Poisoning: ___ mg/kg IV push every 15 minutes until decreased secretions; 1mg IM every 15 minutes if NO IV ## Footnote For Atropine
0.05
161
# Finish this sentence: ATROPINE -(Atropine)/___cholinergic, parasympatholytic
Anti
162
# Finish this sentence: INDICATIONS: Severe pain, pain, and ___ associated with CPAP use in pulmonary edema ## Footnote For fentanyl
anxiety
163
# Finish this sentence: Cholinergic Poisoning: 0.05 ___/___ IV push every 15 minutes until decreased secretions; 1mg IM every 15 minutes if NO IV ## Footnote For Atropine
mg/kg
164
(Pneumoultramicroscopicsilico___coniosis) lung disease from inhaling very fine ash and sand (or “silica dust”); also known as silicosis or the black lung
volcano
165
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to ___ airway with ET tube ## Footnote For Naloxone
securing
166
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe hepatic or renal impairment * Severe ___ depression * Severe bronchial asthma * Paralytic ileus ## Footnote For fentanyl
respiratory
167
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and ___ doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
subsequent
168
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO ___ -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
doses
169
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac output and decreases chance of ___ ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
ventricular
170
# Finish this sentence: ADVERSE REACTIONS: Pulmonary edema, severe agitation, hypertension, dysrhythmias, & ___ ## Footnote For Naloxone
tachycardia
171
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/kg rapid IV push every 5 minutes, minimum dose 0.1 mg. Max dose: 1 mg child; 2 ___ adolescent. ## Footnote For Atropine
mg
172
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose ___ mcg ## Footnote For fentanyl
200
173
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO ___ for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
push
174
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe hepatic or renal impairment * Severe respiratory depression * ___ bronchial asthma * Paralytic ileus ## Footnote For fentanyl
Severe
175
(Sphenopalatine Ganglio___) brain freeze; having a headache from ice cream
neuralgia
176
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/kg rapid IV push every 5 minutes, minimum dose 0.1 mg. Max dose: 1 mg child; 2 mg ___. ## Footnote For Atropine
adolescent
177
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Reverses the effects of all narcotics. Blocks opioid ___ which prevent narcotics from binding. ## Footnote For Naloxone
receptors
178
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for ___ TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
FIRST
179
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, ___, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
diaphoresis
180
# Finish this sentence: ATROPINE -(Atropine)/Anticholinergic, para___
sympatholytic
181
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and ___ pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
increases
182
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in ___, thus improving cardiac output and decreases chance of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
bradycardia
183
# Finish this sentence: INDICATIONS: ___ pain, pain, and anxiety associated with CPAP use in pulmonary edema ## Footnote For fentanyl
Severe
184
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = ___-___ mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
0.5-1.0
185
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe hepatic or renal impairment * Severe respiratory ___ * Severe bronchial asthma * Paralytic ileus ## Footnote For fentanyl
depression
186
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. ___ > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
Pediatric
187
Sternutate
sneeze
188
# Finish this sentence: CONTRAINDICATIONS: ___ ICP * Severe hepatic or renal impairment * Severe respiratory depression * Severe bronchial asthma * Paralytic ileus ## Footnote For fentanyl
Increased
189
(___) inability to recognize faces
Prosopagnosia
190
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg ___ IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
slow
191
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-___ mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
2.0
192
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, ___ improving cardiac output and decreases chance of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
thus
193
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow complex (Mobitz Type I) AV ___ * Cholinergic poisoning (organophosphate or nerve agents) ## Footnote For Atropine
block
194
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-___ mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
2.0
195
# Finish this sentence: CONTRAINDICATIONS: Known sensitivity to the ___ ## Footnote For Naloxone
drug
196
# Finish this sentence: ADVERSE REACTIONS: Drowsiness * Nausea / ___ * Respiratory depression, apnea * Bradycardia ## Footnote For fentanyl
vomiting
197
(Photalgia) when your eyes hurt whenever you step outside because it’s too bright; light-induced pain of the ___
irises
198
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as ___. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
narcotics
199
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from ___ nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
sensory
200
# Finish this sentence: ADVERSE REACTIONS: Pulmonary ___, severe agitation, hypertension, dysrhythmias, & tachycardia ## Footnote For Naloxone
edema
201
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for ___ and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
THIRD
202
# Finish this sentence: ADVERSE REACTIONS: Drowsiness * Nausea / vomiting * Respiratory depression, apnea * ___ ## Footnote For fentanyl
Bradycardia
203
(Photalgia) when your eyes hurt whenever you ___ outside because it’s too bright; light-induced pain of the irises
step
204
# Finish this sentence: Cholinergic Poisoning: 0.05 mg/kg IV push every 15 minutes until decreased secretions; 1 ___ IM every 15 minutes if NO IV ## Footnote For Atropine
mg
205
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ___ ___ ## Footnote For Naloxone
ET tube
206
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push ___/___/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
IV & IO
207
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain ___, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
threshold
208
# Finish this sentence: INDICATIONS: Severe pain, pain, and anxiety ___ with CPAP use in pulmonary edema ## Footnote For fentanyl
associated
209
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac ___ and decreases chance of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
output
210
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose ___ mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
300
211
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/___/___. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
IM & IN
212
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart ___ in bradycardia, thus improving cardiac output and decreases chance of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
rate
213
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate receptors in the CNS, reducing ___ from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
stimuli
214
Paresthesia
tingling or prickling of the skin, also known as “pins and needles” or a limb “falling asleep”
215
(Sphenopalatine ___neuralgia) brain freeze; having a headache from ice cream
Ganglio
216
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow complex (Mobitz Type I) AV block * Cholinergic poisoning (organo___ or nerve agents) ## Footnote For Atropine
phosphate
217
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Reverses the effects of all narcotics. ___ opioid receptors which prevent narcotics from binding. ## Footnote For Naloxone
Blocks
218
# Finish this sentence: DOSAGE: Adult Dose = ___ mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
1
219
# Finish this sentence: NALOXONE-(Narcan)/ ___ antagonist
Narcotic
220
# Finish this sentence: Cholinergic Poisoning: 0.05 mg/kg IV push every 15 minutes until decreased secretions; ___ mg IM every 15 minutes if NO IV ## Footnote For Atropine
1
221
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every ___ minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
5
222
# Finish this sentence: INDICATIONS: ___ overdose. Unresponsiveness of unknown etiology ## Footnote For Naloxone
Narcotic
223
# Finish this sentence: Pediatric Bradycardia: 0.02 ___/kg rapid IV push every 5 minutes, minimum dose 0.1 mg. Max dose: 1mg child; 2mg adolescent. ## Footnote For Atropine
mg
224
# Finish this sentence: DOSAGE: Adult Bradycardia: 1 mg rapid IV ___ every 3-5 minutes (max dose 3 mg) ## Footnote For Atropine
push
225
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow ___ (Mobitz Type I) AV block * Cholinergic poisoning (organophosphate or nerve agents) ## Footnote For Atropine
complex
226
Rhinorrhea
runny nose
227
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases ___ threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
pain
228
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing ___ with ET tube ## Footnote For Naloxone
airway
229
(___ultramicroscopicsilicovolcanoconiosis) lung disease from inhaling very fine ash and sand (or “silica dust”); also known as silicosis or the black lung
Pneumo
230
# Finish this sentence: INDICATIONS: ___ bradycardia * Narrow complex (Mobitz Type I) AV block * Cholinergic poisoning (organophosphate or nerve agents) ## Footnote For Atropine
Symptomatic
231
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow complex (Mobitz Type I) AV block * Cholinergic poisoning (organophosphate or nerve ___) ## Footnote For Atropine
agents
232
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe hepatic or renal impairment * Severe respiratory depression * Severe bronchial asthma * Paralytic ___ ## Footnote For fentanyl
ileus
233
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/___, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
kg
234
# Finish this sentence: DOSAGE: Adult Bradycardia: 1 mg rapid IV push every 3-5 ___ (max dose 3 mg) ## Footnote For Atropine
minutes
235
# Finish this sentence: ADVERSE REACTIONS: Drowsiness * Nausea / vomiting * Respiratory depression, ___ * Bradycardia ## Footnote For fentanyl
apnea
236
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving ___ output and decreases chance of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
cardiac
237
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Reverses the ___ of all narcotics. Blocks opioid receptors which prevent narcotics from binding. ## Footnote For Naloxone
effects
238
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac output and decreases chance of ventricular ectopy. Dries mucous ___ in ___phosphate poisoning. ## Footnote For Atropine
organo
239
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ___ IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
ml
240
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/___ push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
IO
241
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow ___/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
IV
242
# Finish this sentence: ___ -(Atropine)/Anticholinergic, parasympatholytic
ATROPINE
243
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ___ pain pathways. ## Footnote For fentanyl
ascending
244
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 ___. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
mins
245
# Finish this sentence: DOSAGE: Adult Bradycardia: ___ mg rapid IV push every 3-5 minutes (max dose 3 mg) ## Footnote For Atropine
1
246
# Finish this sentence: CONTRAINDICATIONS: Increased ICP * Severe hepatic or renal impairment * Severe respiratory depression * Severe bronchial asthma * ___ ileus ## Footnote For fentanyl
Paralytic
247
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac output and decreases chance of ventricular ectopy. Dries ___ membranes in organophosphate poisoning. ## Footnote For Atropine
mucous
248
(Paresthesia) tingling or prickling of the skin, also known as “pins and needles” or a ___ “falling asleep”
limb
249
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/kg rapid IV push every 5 minutes, minimum dose 0.1 mg. Max dose: 1 mg ___; 2mg adolescent. ## Footnote For Atropine
child
250
(Paresthesia) ___ or prickling of the skin, also known as “pins and needles” or a limb “falling asleep”
tingling
251
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate receptors in the ___, reducing stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
CNS
252
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses ___-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
-0.4
253
(Paresthesia) tingling or prickling of the skin, also known as “pins and needles” or a limb “___ ____”
falling asleep
254
# Finish this sentence: DOSAGE: Adult Bradycardia: 1 mg rapid IV push every ___-5 minutes (max dose 3 mg) ## Footnote For Atropine
3
255
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: ___ pain perception and increases pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
Alters
256
# Finish this sentence: CONTRAINDICATIONS: Known ___ to the drug ## Footnote For Naloxone
sensitivity
257
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow complex (Mobitz Type I) AV block * Cholinergic poisoning (organophosphate or ___ agents) ## Footnote For Atropine
nerve
258
# Finish this sentence: DOSAGE: Adult Bradycardia: 1 mg rapid IV push every 3-___ minutes (max dose 3 mg) ## Footnote For Atropine
5
259
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/___ rapid IV push every 5 minutes, minimum dose 0.1 mg. Max dose: 1mg child; 2mg adolescent. ## Footnote For Atropine
kg
260
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent ___, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
doses
261
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow complex (Mobitz Type I) AV block * ___ poisoning (organophosphate or nerve agents) ## Footnote For Atropine
Cholinergic
262
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative ___ 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
dose
263
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat ___ mins - Max cumulative dose 12 mg ## Footnote For Naloxone
q2-3
264
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate receptors in the CNS, reducing stimuli from sensory nerve endings and ___ ascending pain pathways. ## Footnote For fentanyl
inhibiting
265
# Finish this sentence: INDICATIONS: Symptomatic ___ * Narrow complex (Mobitz Type I) AV block * Cholinergic poisoning (organophosphate or nerve agents) ## Footnote For Atropine
bradycardia
266
# Finish this sentence: ATROPINE -(___)/Anticholinergic, parasympatholytic
Atropine
267
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Reverses the effects of all narcotics. Blocks opioid receptors which prevent narcotics from ___. ## Footnote For Naloxone
binding
268
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac ___ and decreases chance of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
output
269
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and ___ doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
subsequent
270
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow complex (___ Type I) AV block * Cholinergic poisoning (organophosphate or nerve agents) ## Footnote For Atropine
Mobitz
271
(Procidentia) the descent of any ___ organ (prolapse)
internal
272
# Finish this sentence: Cholinergic Poisoning: 0.05 mg/kg IV push every 15 minutes until decreased secretions; 1 mg ___ every 15 minutes if NO IV ## Footnote For Atropine
IM
273
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max ___ mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
100
274
# Finish this sentence: DOSAGE: Adult Dose = 1 mcg/kg, max ___ mcg, slow push IV/IO/IM/IN. Repeat = Every 5 minutes, max cumulative dose 300 mcg. Pediatric Dose = 0.5-1.0 mcg/kg, max 100 mcg, slow push IV/IO/IM/IN Repeat = 0.5 mcg/kg, max 50 mcg, every 5 minutes, max cumulative dose 200 mcg ## Footnote For fentanyl
100
275
(Photalgia) when your ___ hurt whenever you step outside because it’s too bright; light-induced pain of the irises
eyes
276
# Finish this sentence: Cholinergic Poisoning: 0.05 mg/kg IV push every 15 minutes until decreased secretions; 1 mg IM every ___ minutes if NO IV ## Footnote For Atropine
15
277
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/kg rapid IV push every 5 minutes, minimum dose 0.1 mg. Max dose: ___ mg child; 2mg adolescent. ## Footnote For Atropine
1
278
Sphenopalatine Ganglioneuralgia
brain freeze; having a headache from ice cream
279
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May precipitate opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to ___ that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
patients
280
# Finish this sentence: ADVERSE REACTIONS: Drowsiness * ___ / vomiting * Respiratory depression, apnea * Bradycardia ## Footnote For fentanyl
Nausea
281
(Pneumo___microscopicsilicovolcanoconiosis) lung disease from inhaling very fine ash and sand (or “silica dust”); also known as silicosis or the black lung
ultra
282
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. ___-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
0.4
283
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to ___ receptors in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
opiate
284
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac output and decreases chance of ventricular ectopy. Dries mucous ___ in organophosphate ___. ## Footnote For Atropine
poisoning
285
# Finish this sentence: DOSAGE:Adult: ___ mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
4
286
# Finish this sentence: ADVERSE REACTIONS: Flushed skin * Tachycardia * Dry mouth * ___ pupils * Delirium * Blurred vision * headache ## Footnote For Atropine
Dilated
287
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/kg rapid IV push every 5 minutes, minimum dose ___ mg. Max dose: 1mg child; 2mg adolescent. ## Footnote For Atropine
0.1
288
(___) fever
Pyrexia
289
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow complex (Mobitz Type I) AV block * Cholinergic poisoning (___phosphate or nerve agents) ## Footnote For Atropine
organo
290
# Finish this sentence: DOSAGE: Adult Bradycardia: 1 mg rapid IV push every 3-5 minutes (max dose ___ mg) ## Footnote For Atropine
3
291
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus improving cardiac output and decreases chance of ventricular ectopy. Dries mucous ___ in organo___ poisoning. ## Footnote For Atropine
phosphate
292
# Finish this sentence: PRECAUTIONS: Naloxone does not last as long as narcotics. May ___ opioid withdrawal syndrome (anxiety, agitation, GI distress, vomiting, diaphoresis, and yawning). Naloxone should not be given to patients that have been intubated. Naloxone should be considered prior to securing airway with ET tube ## Footnote For Naloxone
precipitate
293
# Finish this sentence: Fentanyl - (Sublimaze, Duragsesic, ___, Fentora) / Opiate agonist
Actiq
294
# Finish this sentence: DOSAGE: Adult Bradycardia: 1 mg rapid ___ push every 3-5 minutes (max dose 3 mg) ## Footnote For Atropine
IV
295
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate receptors in the CNS, ___ stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
reducing
296
(___) runny nose
Rhinorrhea
297
# Finish this sentence: DOSAGE:Adult: 4 ___ / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
mg
298
(Proctalgia) literal pain in the ___
butt
299
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Reverses the effects of all ___. Blocks opioid receptors which prevent narcotics from binding. ## Footnote For Naloxone
narcotics
300
# Finish this sentence: ADVERSE REACTIONS: Pulmonary edema, severe ___, hypertension, dysrhythmias, & tachycardia ## Footnote For Naloxone
agitation
301
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. ___ cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
Max
302
# Finish this sentence: Pediatric Bradycardia: 0.02 mg/kg rapid IV push every 5 minutes, minimum dose 0.1 mg. Max dose: 1 mg child; ___ mg adolescent. ## Footnote For Atropine
2
303
# Finish this sentence: ___-(Narcan)/ Narcotic antagonist
NALOXONE
304
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST TWO doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > ___ kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
4
305
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Alters pain perception and increases pain threshold, Binds to opiate ___ in the CNS, reducing stimuli from sensory nerve endings and inhibiting ascending pain pathways. ## Footnote For fentanyl
receptors
306
# Finish this sentence: INDICATIONS: Symptomatic bradycardia * Narrow complex (Mobitz Type I) ___ block * Cholinergic poisoning (organophosphate or nerve agents) ## Footnote For Atropine
AV
307
(Procidentia) the ___ of any internal organ (prolapse)
descent
308
# Finish this sentence: DESIRED EFFECTS/MECHANISM OF ACTION: Accelerates heart rate in rate, thus ___ cardiac output and decreases chance of ventricular ectopy. Dries mucous membranes in organophosphate poisoning. ## Footnote For Atropine
improving
309
(Photalgia) when your eyes hurt whenever you step outside because it’s too ___; light-induced pain of the irises
bright
310
# Finish this sentence: DOSAGE:Adult: 4 mg / 0.1 ml IN for FIRST ___ doses -0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins. Max cumulative dose 12 mg. Pediatric > 4 kg: 4 mg / 0.1 ml IN for FIRST TWO doses. 0.4-2.0 mg slow IV/IO push for THIRD and subsequent doses, may repeat q2-3 mins - Max cumulative dose 12 mg ## Footnote For Naloxone
TWO
311
# Finish this sentence: NALOXONE-(___)/ Narcotic antagonist
Narcan
312
# Finish this sentence: PRECAUTIONS: Renal disease * CHF * ___ ___ ## Footnote For Atropine
Down’s Syndrome
313
# Finish this sentence: INDICATIONS: Narcotic overdose. ___ of unknown etiology ## Footnote For Naloxone
Unresponsiveness